CurrentCentenePolicy CP.MP.133

Posterior Tibial Nerve Stimulation for Voiding Dysfunction

Defines medical necessity, coverage criteria, and coding guidance for percutaneous posterior tibial nerve stimulation to treat overactive bladder (OAB) and related voiding dysfunction for Centene-affiliated health plans.

Policy Summary

PayerCentene

PolicyPosterior Tibial Nerve Stimulation for Voiding Dysfunction

Policy CodePolicy CP.MP.133

Change TypeNo material changes

Effective Date

Next Review Date

Key ActionObtain prior authorization for percutaneous PTNS (CPT 64566) documenting OAB diagnosis, failure of conservative management, and completion of the 12-session initial regimen.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

12initial weekly 30-minute sessions in standard regimen

64566covered CPT code

0587T-0590Timplantable system codes not covered

monthlymaintenance frequency

Coverage and Medical Necessity Criteria

Initial PTNS therapy

PTNS is medically necessary when ALL of the following are met:

Initial therapy criteria: A. Diagnosis of overactive bladder (OAB);

Document diagnosis of OAB.

Initial therapy criteria: B. Failure of conservative medical management (e.g., behavioral therapies such as bladder training or pelvic floor muscle training, or pharmacotherapy with oral medications used with the intent to treat OAB), unless conservative management is not desired or is medically contraindicated;

Document prior conservative therapies, contraindications, or patient declines.

Initial therapy criteria: C. Service is provided in accordance with the standard treatment regimen of 30-minute weekly sessions for 12 weeks;30-minute weekly sessions x 12

Policy Summary

PayerCentene

PolicyPosterior Tibial Nerve Stimulation for Voiding Dysfunction

Policy CodePolicy CP.MP.133

Change TypeNo material changes

Effective Date

Next Review Date

Key ActionObtain prior authorization for percutaneous PTNS (CPT 64566) documenting OAB diagnosis, failure of conservative management, and completion of the 12-session initial regimen.

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Maintenance PTNS

Maintenance therapy:

Maintenance therapy: Once-a-month maintenance treatments with PTNS are medically necessary for patients who experience significant improvement in their OAB symptoms after the 12 initial treatments;response after initial 12 sessions required

Treatment frequency may vary depending on return of symptoms; frequency should be individualized and documented (monthly is typical).

Maintenance therapy should be considered only for patients who demonstrated significant symptomatic improvement during the initial 12-week course and whose ongoing benefit is documented;

Document response to initial series if requesting maintenance.

Not supported/insufficient evidence

Limitations / insufficient evidence:

Evidence limitations: There is insufficient evidence to support the use of PTNS beyond 12 months or when there is no improvement in urinary dysfunction;

Discontinue or do not continue PTNS when no clinical improvement is observed.

Evidence limitations: There is insufficient evidence in the published peer‑reviewed literature to support the use of implantable tibial nerve stimulation systems for the treatment of urinary voiding dysfunction;

Implantable tibial nerve stimulation devices and related implantation/revision/programming procedures (e.g., CPT codes 0587T–0590T) are not supported by this policy.

CPT and Related Codes

CPT codes that support medical necessityCPTCovered

64566

Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming

CPT codes that do not support medical necessityCPTNot Covered

0587T	Percutaneous implantation or replacement of integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generator, including analysis, programming and imaging guidance when performed, posterior tibial nerve.
0588T	Revision or removal of percutaneously placed integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generator, including analysis, programming, and imaging guidance when performed, posterior tibial nerve.
0589T	Electronic analysis with simple programming of implanted integrated neurostimulation system for bladder dysfunction (eg, electrode array and receiver), including contact group(s), amplitude, pulse width, frequency (Hz), on/off cycling, burst, dose lockout, patient-selectable parameters, responsive neurostimulation, detection algorithms, closed-loop parameters, and passive parameters, when performed by physician or other qualified health care professional, posterior tibial nerve, 1-3 parameters.
0590T	Electronic analysis with complex programming of implanted integrated neurostimulation system for bladder dysfunction (eg, electrode array and receiver), including contact group(s), amplitude, pulse width, frequency (Hz), on/off cycling, burst, dose lockout, patient-selectable parameters, responsive neurostimulation, detection algorithms, closed-loop parameters, and passive parameters, when performed by physician or other qualified health care professional, posterior tibial nerve, 4 or more parameters.

Provider Requirements, Authorization, and Documentation

Prior Authorization

Prior Authorization Required

Prior authorization is required for posterior tibial nerve stimulation (PTNS) when billing CPT 64566. Submit a completed prior authorization request with supporting clinical documentation prior to performing the service when required by the member’s plan.

Affected code: CPT 64566 (Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming)

Step Therapy

Conservative Management Prerequisite

Conservative management must be attempted and documented prior to PTNS unless such management is not desired by the patient or is medically contraindicated. Examples of conservative therapies include behavioral interventions (e.g., bladder training, pelvic floor muscle training) and pharmacotherapy with oral medications intended to treat overactive bladder (OAB).

Documentation must show failure of conservative therapies, intolerance, contraindication, or patient refusal before approval of PTNS
Typical protocol: 30-minute weekly sessions for 12 weeks

Documentation Required

Required Documentation for PTNS

Documentation must include: diagnosis of overactive bladder (OAB); records of prior conservative management attempts (types of therapy, medication names, doses, dates, and documented clinical response or intolerance); the planned PTNS treatment regimen (30-minute weekly sessions for 12 weeks) and location of service; and objective or subjectively reported symptom improvement after initial sessions when requesting maintenance treatment.

Required: clinical notes showing OAB diagnosis and rationale for PTNS
Required: documentation of behavioral therapy and/or pharmacotherapy trials with dates and outcomes, or documentation of contraindication/refusal
Required for maintenance: documentation of significant symptom improvement after the initial 12 weekly treatments and proposed maintenance frequency

Denial Risk

Implantable System Codes Not Supported

Claims for implantable tibial nerve stimulation systems and related implantation/revision/programming codes are not supported as medically necessary by this policy.

Not supported codes: 0587T, 0588T, 0589T, 0590T (implantation, revision/removal, and programming of implantable tibial nerve stimulation systems)

Clinical Background

Overactive bladder (OAB) is characterized by urinary urgency, frequency, urge incontinence, and nocturia and can substantially affect quality of life. Posterior tibial nerve stimulation (PTNS) is a minimally invasive neuromodulation technique that stimulates the posterior tibial nerve—typically via a percutaneous needle electrode near the medial malleolus—to indirectly modulate sacral nerve activity and reduce OAB symptoms. The standard PTNS regimen described in this policy is 30‑minute weekly sessions for 12 weeks, with responders often showing improvement by 6–8 sessions and eligible patients offered monthly maintenance treatments thereafter as needed.

Key Terms

inv-13: PTNS — Posterior tibial nerve stimulation (definition/key points)

TechniquePercutaneous posterior tibial nerve stimulation (PTNS) is a minimally invasive electrical neuromodulation technique that stimulates the posterior tibial nerve via a 34‑gauge needle electrode placed near the medial malleolus with a surface electrode on the foot.

Stimulation parametersTypical settings: 0.5–9 mA current at 20 Hz for a 30‑minute session.

Standard initial regimenInitial course typically consists of 12 weekly 30‑minute sessions; responders often show improvement by 6–8 sessions.

MechanismIndirect modulation of the sacral nerve plexus (the neural control of bladder function) via stimulation of the posterior tibial nerve.

Implantable systemsSeveral implantable tibial nerve neuromodulation systems are under investigation (including leadless implants), but current evidence on benefits/efficacy is limited.

inv-14: OAB — Overactive bladder definition (urgency, frequency, urge incontinence, nocturia)

Core symptomsOveractive bladder (OAB) is defined by urinary urgency, urinary frequency, urge urinary incontinence, and nocturia.

Clinical impactOAB can significantly impair quality of life, affecting physical function, sexual function, and social interactions.

Related termOAB is a specific type of voiding dysfunction, which broadly includes urinary incontinence, retention, and symptoms of frequency and urgency.